![](https://nthumb.tpgimages.com/mid2_com_img/1339/29142/TOP27148771.jpg)
Paxlovid components, molecular models. The image shows the two components of paxlovid, PF-07321332 (bottom) and ritonavir (top). PF-07321332 is a new antiviral drug acting as a protease inhibitor in the treatment of COVID-19. Ritonavir slows down the metabolism of PF-07321332. As of 2021, paxlovid is in phase III trials.
px | px | dpi | = | cm | x | cm | = | MB |
Details
Creative#:
TOP27148771
Source:
達志影像
Authorization Type:
RM
Release Information:
須由TPG 完整授權
Model Release:
N/A
Property Release:
N/A
Right to Privacy:
No
Same folder images: